MIX (150 mg/m z ) was given iv Followed by a 4 hour contlneus infusion of 150 mg/m z MTX. 5-F0 was injected iv 7 hours after starting the MIX inFusion. ADM was injected by iv bolus before or after MTX. 5o avoid toxicity due to MIX patients received 500 to i000 ml of sodium chloride 0.9% or glucose 5% before and 3000 ml after appllcatlon of MTX as well as sodlum bicarbonate For alkallzation. 38 patients, 13 women and 25 men, with a median age of 59 years entered the study. In the 26 patients with measurable tumor 5 died within the first chemotherapeutic cycle (early death), i still could not be evaluated for response. Out of the remaining 20 patients we observed 0 CR, 6 PR, 9 SD and 5 P suggesting a preliminary response rate of 6/20 (30%). The median survival of 31 patients was 5.3 months, of the PR 9.3 months, and P 4.7 months, respectively.
FEM was well tolerated with moderate haematological toxicity and low grade alopecia. It does not show higher activity than FAM, but a dose escalation seems to be possible in future trial.
Chemotherapiegruppe gastrointestinaler Tumoren (CGT).
